Literature DB >> 15359269

Photodynamic therapy for maculopathy due to radiation retinopathy.

S J Bakri1, P M Beer.   

Abstract

BACKGROUND/AIMS: To describe the clinical outcomes of four eyes with macular oedema due to radiation retinopathy treated with verteporfin photodynamic therapy (PDT).
METHODS: Interventional Case Series. Four charts of four patients who underwent PDT for macular oedema due to radiation retinopathy were reviewed. Snellen visual acuities, clinical examination and fundus photographs were performed before and after PDT. Main outcome measures were visual acuity, clinical examination before and after PDT.
RESULTS: All four eyes had a marked reduction in hard exudates. Three of four eyes had an improvement in vision following the PDT.
CONCLUSION: PDT may have a role in the treatment of macular oedema due to radiation retinopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15359269     DOI: 10.1038/sj.eye.6701637

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

Review 1.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

2.  Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Authors:  Ivana K Kim; Anne Marie Lane; Purva Jain; Caroline Awh; Evangelos S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 3.  Effects of radiotherapy on uveal melanomas and adjacent tissues.

Authors:  C Groenewald; L Konstantinidis; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

4.  Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant.

Authors:  Andrea Russo; Teresio Avitabile; Maurizio Uva; Salvatore Faro; Livio Franco; Marisa Sanfilippo; Seby Gulisano; Mario Toro; Vittorio De Grande; Stefania Rametta; Laura Foti; Antonio Longo; Michele Reibaldi
Journal:  Case Rep Ophthalmol       Date:  2012-02-25

5.  Intravitreal Aflibercept in Recalcitrant Radiation Maculopathy due to External Beam Radiotherapy for Nasopharyngeal Cancer: A First Case Report.

Authors:  Eleni Loukianou; Georgia Loukianou
Journal:  Case Rep Ophthalmol       Date:  2017-02-02

6.  Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®).

Authors:  Soraya Alessandra Horowitz; Nadyr P Damasceno; Eduardo F Damasceno
Journal:  Int Med Case Rep J       Date:  2020-02-11

7.  High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema.

Authors:  Mohammed Ali Khan; Arman Mashayekhi; Kyle Ferguson; Jerry A Shields; Carol L Shields
Journal:  Ocul Oncol Pathol       Date:  2017-01-27

8.  Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity.

Authors:  Nisha V Shah; Samuel K Houston; Arnold M Markoe; William Feuer; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2012-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.